Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
Viral-Human Chimeric Transcript Predisposes Risk to Liver Cancer Development and Progression
复制标题
DOI:
10.1016/j.ccr.2014.01.030
复制
发表时间:
2014-03-17
期刊:
影响因子:
50.3
通讯作者:
Wong, Nathalie
中科院分区:
文献类型:
--
作者:
Lau, Chi-Chiu;Sun, Tingting;Wong, Nathalie
The mutagenic effect of hepatitis B (HBV) integration in predisposing risk to hepatocellular carcinoma (HCC) remains elusive. In this study, we performed transcriptome sequencing of HBV-positive HCC cell lines and showed transcription of viral-human gene fusions from the site of genome integrations. We discovered tumor-promoting properties of a chimeric HBx-LINE1 that, intriguingly, functions as a hybrid RNA. HBx-LINE1 can be detected in 23.3% of HBV-associated HCC tumors and correlates with poorer patient survival. HBx-LINE1 transgenic mice showed heightened susceptibility to diethylnitrosamine-induced tumor formation. We further show that HBx-LINE1 expression affects beta-catenin transactivity, which underlines a role in activating Wnt signaling. Thus, this study identifies a viral-human chimeric fusion transcript that functions like a long noncoding RNA to promote HCC.